Dear Leftists... Dear Leftists Posted on October 14,

New Post Public Reply Private Reply Replies (1) Message Board
energy_wave energy_wave #71203
236
Dear Leftists...

Quote:
Dear Leftists
Posted on October 14, 2021 by rthtgnbs

You hated Reagan, and you hated Bush (both of them), you loved Clinton and Obama, and you hate Trump, and now when responding to any issue with Biden you bring up Trump.

Reagan didn’t start a nuclear war with Russia. The Bushes both had problems with foreign policy, getting the US involved in wars in the middle east (but in terms of military deployments Clinton and Obama weren’t playing tiddlywinks either). Trump actually decreased operations, and Biden’s disastrous exit from Afghanistan cannot be spun into anything but an executive giving orders that ignored the input of the intelligence community and defense leadership.

But how did you get Reagan? How did you get Trump? You got Reagan and Trump by forcing Carter and Obama on America. You got Carter by weaponizing journalists to go after Nixon. You got Obama by having journalists utterly shill for Obama and, I directly quote “not do their jobs” during the Obama years (including helping him get elected). The media was so in the corner for Biden that it wasn’t even funny, simply sad.

But…how did you get Nixon? Well, clearly bombing the hell out of America by the paramilitary wing of the Democratic party (the Weather Underground then, Antifa now) didn’t work at stopping a Republican from taking the White House. So yeah, that’s a surefire recipe for a successful “people’s revolution!” isn’t it? Of course now Biden is in office, so Antifa slowed down the hashtag resistance

Which makes me cringe a little when I read idiocy like this, which justifies killing people in the name of advancing the Leftist cause. https://www.politico.com/magazine/story/2018/...020-218947 and https://www.politico.com/magazine/story/2018/...nce-218948 .

Look Leftists, we know you are really hardcore Marxists at heart. You talk about “democratic socialism” as being different from real socialism because this time you really REALLY want the people to vote on the farm and factory quotas rather than a central committee. Newsflash, the rest of America knows you are Marxist, and we find it refreshing when you talk of bombing government workers who are working for a President you don’t like (even if they are doing the exact same work they did for your guy, somehow it’s icky now that Trump is in office rather than the Deporter in Chief).

But finally, it’s time to shit or get off the pot. Start the glorious revolution you so dearly desire if you truly mean it. Or shut up about it. Cause I for one am sick and tired of hear about how you want to punch non-Leftists in the face and kill their families. Or force them to get a shot in the arm. Or have the FBI investigate parents who prefer readin’, writin’ and ‘rithmatic to teaching elementary school children critical race theory that is simply cultural Marxism.

Now…this may cause me to rethink my stance on the 30-30 as the ideal survivalist rifle, only because a 30 round magazine is really convenient when you are outnumbered by a mob of Leftists. But then again, the Kenosha Kid didn’t need all 30 rounds to make it to safety either.


https://wanderingthroughthenight.wordpress.co...eftists-2/
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Montessori and Tech: A New Era of Integration

Updated Category News Views 19

Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 12

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 2

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Dr. Anderson’s Journey: Leadership with Faith and Service

Updated Category News Views 4

A Life Shaped by Service Dr. Howard Anderson isn't just another name in a glossy award roster—he's a powerhouse of leadership, a chaplain of compassion, and a soldier in spirit. Honored as a Pinnacle Professional Member of The Inner Circle of Excellence, his recognition feels less like an accolade and more like a testament to a life committed to serving others. The...

Continue Reading
New American Funding Expands in Carolinas with Mullinix Move

Updated Category News Views 27

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 5

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 28

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 30

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 5

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 23

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading

Top 5 Most Recently Viewed Articles

Opportunity for Ibotta Investors: Lead a Class Action Lawsuit

Updated Category News Views 214

Enhancing Investor Rights in Ibotta, Inc. Class Action The Rosen Law Firm, recognized for its commitment to global investor rights, is reaching out to purchasers of Ibotta, Inc. (NYSE: IBTA) regarding the recent developments surrounding its initial public offering (IPO). Investors who participated in the IPO may have the chance to be part of a class action lawsuit that...

Continue Reading
GETESA and Comviva Join Forces to Revolutionize Digital Payments

Updated Category News Views 273

GETESA and Comviva Join Forces to Revolutionize Digital Payments GETESA Money S.A., a prominent subsidiary of GETESA, is set to introduce pioneering digital payment services using Comviva's mobiquity® Pay platform. This strategic partnership marks a significant step towards enhancing digital financial transactions, aiming to foster a cash-lite economy. Innovative Payment...

Continue Reading
Analyzing Monolithic Power Systems in the Semiconductor Arena

Updated Category News Views 97

Understanding the Semiconductor Landscape Investors and analysts alike are continually on the lookout for valuable insights in the ever-changing landscape of the semiconductor industry. A closer examination of key players, such as Monolithic Power Systems (NASDAQ: MPWR), can reveal a lot about market trends and company performance. By comparing financial metrics and...

Continue Reading
Transforming Manufacturing: How SendCutSend Leads Innovation

Updated Category News Views 212

SendCutSend Drives Business Growth with Innovative Tools SendCutSend has positioned itself as a key player in American manufacturing by offering robust enterprise features for various industries. The company is experiencing a significant surge in demand for its tailored business tools that cater specifically to the needs of engineering teams, purchasing departments, and...

Continue Reading
SciBase's Nevisense: Skin Health Game-Changer or Hype?

Updated Category News Views 161

SciBase Holding AB (STO: SCIB) has stirred the pot with its latest claims about Nevisense and atopic dermatitis predictions—this study hit the radar on February 17, 2026. It’s set to be presented at the AAAAI conference from February 27 to March 2. Sounds like a breakthrough, right? Well, let’s dissect what this really means for traders sitting on that stock....

Continue Reading